Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03097770 |
|---|---|
| Brief Title: | Treatment of Relapsed and/or Chemotherapy Refractory B-cell Malignancy by Tandem CAR T Cells Targeting CD19 and CD20 |
| First Submitted : | March 26, 2017 |
| First Submitted that Met QC Criteria : | March 26, 2017 |
| First Posted : | March 31, 2017 |
| Last Update Submitted that Met QC Criteria : | August 31, 2020 |
| Last Update Posted : | September 2, 2020 |